The Prognostic Significance of Wnt-5a Expression in Primary Breast Cancer Is Extended to Premenopausal Women
Figure 3
Recurrence-free survival according to Wnt-5a expression and tamoxifen treatment in ER+ patients.
Kaplan–Meier estimates of recurrence free survival according to Wnt-5a status in ER+ patients with high/low proliferation rates A. NGH I–II, B. NGH III. Kaplan–Meier estimates of recurrence free survival according to tamoxifen treatment in C. Wnt-5a −/++, and D. Wnt-5a ++/+++ patients.